Ocean Transportation Intermediary License Reissuances, 49446 [2012-20079]

Download as PDF 49446 Federal Register / Vol. 77, No. 159 / Thursday, August 16, 2012 / Notices Chung J. Park, President, Application Type: QI Change. Your Connexion, Inc. (NVO & OFF), 13280 SW 131 Street, #108, Miami, FL 33186, Officers: Mauricio R. Valencia, President (Qualifying Individual), Mauricio J. Valencia, Secretary, Application Type: New NVO & OFF License. Dated: August 10, 2012. By the Commission. Karen V. Gregory, Secretary. Food and Drug Administration [Docket No. FDA–2012–N–0001] FEDERAL MARITIME COMMISSION Gastrointestinal Drugs Advisory Committee; Notice of Meeting Ocean Transportation Intermediary License Reissuances The Commission gives notice that the following Ocean Transportation Intermediary license has been reissued pursuant to section 40901 of the Shipping Act of 1984 (46 U.S.C. 40101). License No.: 023327N. Name: G & F West Indies Shipping, Inc. Address: 1416 Blue Hill Avenue, Boston, MA 02125. Date Reissued: June 26, 2012. Vern W. Hill, Director, Bureau of Certification and Licensing. [FR Doc. 2012–20079 Filed 8–15–12; 8:45 am] BILLING CODE 6730–01–P FEDERAL MARITIME COMMISSION Ocean Transportation Intermediary License Revocations mstockstill on DSK4VPTVN1PROD with NOTICES [FR Doc. 2012–20081 Filed 8–15–12; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 6730–01–P The Commission gives notice that the following Ocean Transportation Intermediary licenses have been revoked pursuant to section 40901 of the Shipping Act of 1984 (46 U.S.C. 40101) effective on the date shown. License No.: 009931N. Name: Westwind Transportation Services, Inc. dba Westwind Container Line. Address: 1225 West 190th Street, Suite 300, Gardena, CA 90248. Date Revoked: July 16, 2012. Reason: Failed to maintain a valid bond. License No.: 022365F. Name: IVI Freight Systems Inc. Address: 9112 NW 120th Terrace, Hialeah Gardens, FL 33018. Date Revoked: July 28, 2012. Reason: Failed to maintain a valid bond. License No.: 022773F. Name: WLI (USA) Inc. 16:38 Aug 15, 2012 Vern W. Hill, Director, Bureau of Certification and Licensing. BILLING CODE 6730–01–P [FR Doc. 2012–20080 Filed 8–15–12; 8:45 am] VerDate Mar<15>2010 Address: 175–01 Rockaway Blvd., Suite 228, Jamaica, NY 11434. Date Revoked: July 15, 2012. Reason: Failed to maintain a valid bond. Jkt 226001 AGENCY: Food and Drug Administration, HHS. ACTION: Notice. This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public. Name of Committee: Gastrointestinal Drugs Advisory Committee. General Function of the Committee: To provide advice and recommendations to the Agency on FDA’s regulatory issues. DATES: Date and Time: The meeting will be held on October 15, 2012, from 8 a.m. to 5 p.m. Location: FDA White Oak Campus, Building 31, the Great Room, White Oak Conference Center (Rm. 1503), 10903 New Hampshire Ave., Silver Spring, MD 20993–0002. Information regarding special accommodations due to a disability, visitor parking, and transportation may be accessed at: https://www.fda.gov/Advisory Committees/default.htm; under the heading ‘‘Resources for You,’’ click on ‘‘Public Meetings at the FDA White Oak Campus.’’ Please note that visitors to the White Oak Campus must enter through Building 1. Contact Person: Cindy Hong, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 31, Rm. 2528, Silver Spring, MD 20993–0002, 301– 796–9001, FAX 301–847–8533, email: GIDAC@fda.hhs.gov, or FDA Advisory Committee Information Line, 1–800– 741–8138 (301–443–0572 in the Washington, DC area), to find out further information regarding FDA advisory committee information. A notice in the Federal Register about last minute modifications that impact a PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Therefore, you should always check the Agency’s Web site at https://www.fda.gov/Advisory Committees/Calendar/default.htm and scroll down to the appropriate advisory committee meeting link, or call the advisory committee information line to learn about possible modifications before coming to the meeting. Agenda: The committee will provide advice and recommendations to the Agency on the need for and design of clinical development programs necessary to support approval of parenteral lipid emulsion products as nutritional support. FDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its Web site prior to the meeting, the background material will be made publicly available at the location of the advisory committee meeting, and the background material will be posted on FDA’s Web site after the meeting. Background material is available at https://www.fda.gov/ AdvisoryCommittees/Calendar/default. htm. Scroll down to the appropriate advisory committee meeting link. Procedure: Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person on or before September 28, 2012. Oral presentations from the public will be scheduled between approximately 1 p.m. and 2 p.m. Those individuals interested in making formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before September 20, 2012. Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested persons regarding their request to speak by September 21, 2012. Persons attending FDA’s advisory committee meetings are advised that the Agency is not responsible for providing access to electrical outlets. FDA welcomes the attendance of the public at its advisory committee E:\FR\FM\16AUN1.SGM 16AUN1

Agencies

[Federal Register Volume 77, Number 159 (Thursday, August 16, 2012)]
[Notices]
[Page 49446]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-20079]


-----------------------------------------------------------------------

FEDERAL MARITIME COMMISSION


Ocean Transportation Intermediary License Reissuances

    The Commission gives notice that the following Ocean Transportation 
Intermediary license has been reissued pursuant to section 40901 of the 
Shipping Act of 1984 (46 U.S.C. 40101).
    License No.: 023327N.
    Name: G & F West Indies Shipping, Inc.
    Address: 1416 Blue Hill Avenue, Boston, MA 02125.
    Date Reissued: June 26, 2012.

Vern W. Hill,
Director, Bureau of Certification and Licensing.
[FR Doc. 2012-20079 Filed 8-15-12; 8:45 am]
BILLING CODE 6730-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.